Tfh Dysfunction in HIV & Aging

See also
Status	Clinical Trial	Phase
Terminated	`NCT01690637` - Panama and El Salvador Children's Oseltamivir Study	Phase 4
Completed	`NCT03572491` - Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine	Phase 3
Completed	`NCT02387294` - Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents	Phase 3
Completed	`NCT02600585` - Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults	N/A
Completed	`NCT01511744` - Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine	Phase 4
Completed	`NCT02398097` - Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young Subjects	Phase 4
Completed	`NCT01342796` - Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects	Phase 2
Completed	`NCT01677702` - Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization	N/A
Active, not recruiting	`NCT01096225` - Immunogenicity Study of S-OIV H1N1 Influenza Vaccine	N/A
Completed	`NCT00880659` - Bangladesh Secondary Transmission Handwashing Protocol	Phase 2
Completed	`NCT01879553` - Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above	Phase 2
Completed	`NCT01879540` - Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age	Phase 2
Completed	`NCT01651104` - Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects	Phase 2
Completed	`NCT01636102` - Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above	Phase 2
Completed	`NCT03448705` - Safety of 4Fluart ID Suspension for Injection in Adult Subjects	Phase 1
Completed	`NCT02478905` - Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting	N/A
Recruiting	`NCT04431050` - Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens
Completed	`NCT01568788` - Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine	N/A
Completed	`NCT05155319` - Universal Influenza A Vaccine in Healthy Adults	Phase 1
Completed	`NCT01880697` - Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above	Phase 3

NCT number	NCT04487041
Study type	Interventional
Source	University of Miami
Contact	Suresh Pallikkuth, PhD
Phone	3052435315
Email	spallikkuth@med.miami.edu
Status	Recruiting
Phase	Phase 4
Start date	October 30, 2020
Completion date	September 30, 2025

Tfh Dysfunction in HIV and Aging

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms